Objective To analyze the drug resistance of multidrug-resistant organisms (MDROs) and to provide basis for the rational clinical application of antibiotics. Methods 19 198 biological specimens were collected from different clinical departments of Fuyang People's Hospital in 2018. The specimens were isolated and cultured,and the strains were obtained and tested for drug susceptibility. Results 19 198 samples were collected in 2018 and 5605 strains of pathogenic bacteria were isolated,of which 1456 strains showed multidrug resistant,and the detection rate of multidrug-resistant organisms was 25.98%. The main resistant strains were Escherichia coli,Klebsiella pneumoniae,Acinetobacter baumannii,Staphylococcus aureus and Pseudomonas aeruginosa. Multidrug-resistant organisms were detected from sputum accounted for 50.07%. The drug resistance rate of Escherichia coli to ceftriaxone,levofloxacin and compound sulfamethoxazole was over 73.00%,Klebsiella pneumoniae to ceftriaxone was as high as 95.25%,and Staphylococcus aureus to oxacillin and penicillin was over 80%. Conclusion The high resistance rate of multidrug-resistant organisms to conventional antibiotics increased the difficulty of clinical treatment. It’s necessary to strengthen the monitoring of drug-resistant organisms and rational use of antibiotics.
Key words
Multidrug-resistant organisms /
Antibiotics /
Drug resistance monitoring
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Magiorakos AP,Srinivasan A,Carey RB,et al. Multidrug-resistant,extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance[J]. Clin Microbiol Infect,2012.18(3): 268-281.
[2] 胡付品,朱德妹.细菌耐药性监测数据处理应注意的问题[J].中国感染与化疗杂志,2016,16(5):667-672.
[3] 张萌,张辉文.某三甲医院多重耐药菌感染现状及集束干预效果[J].中国感染控制杂志,2017,16(2):169-172.
[4] 陈美恋,贾会学,李六亿,等.多重耐药菌感染监测及防控现状综述[J].中国感染控制杂志,2015,14(8):571-576.
[5] 杨乐,赵丽霞,俞荣彬. 2011年常州市15所医院医院感染现患率调查[J].中国感染控制杂志,2012,11(6):444-447.
[6] 贾会学,贾建侠,赵艳春,等.某综合医院多重耐药菌社区发生感染的现状调查[J].中国感染控制杂志,2012,11(1):21-24.
[7] 中华预防医学会医院感染控制分会.临床微生物标本采集和送检指南[J].中华医院感染学杂志,2018,28(20):3192-3200.
[8] 郭静,李从荣.武汉大学人民医院多重耐药菌感染现状分析[J].检验医学,2018,33(8):716-721.
[9] 周旋,杜贵琴,李雅君,等.ICU和非ICU病房多重耐药菌检出及耐药性差异[J].中国感染控制杂志,2018,17(3):219-223,229.
[10] 花静,王进,汤红芳,等.某医院多重耐药菌感染目标性监测和干预措施[J].中国消毒学杂志,2015,32(9):882-883,886.
[11] 卫生部:发布多重耐药菌医院感染预防与控制技术指南[J].药物不良反应杂志,2011,13(2):108-109.
[12] 杨旭,何薇,王清,等.某三甲综合医院多重耐药菌分布及耐药性分析[J].国际检验医学杂志,2015,36(20):2958-2960.
[13] Gordon NC,Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.[J].Int.J.Antimicrob.Agents,2010,35(3):219-226.
[14] 凌玲,吴伟旋,孙树梅,等.多重耐药菌医院感染直接经济负担的系统评价[J].中国感染控制杂志,2017,16(7):616-621.